Affiliation:
1. Molecular Diagnostics and COVID‐19 Kit Testing Laboratory National Institute of Biologicals (Ministry of Health and Family Welfare) Noida India
2. Academy of Scientific and Innovative Research (AcSIR) Ghaziabad India
Abstract
AbstractBreast cancer, a formidable global health challenge, needs continuous translational research to understand the complexity of mechanisms and improve therapeutic and diagnostic strategies. Breast cancer cell lines are of paramount importance as they significantly contribute to the initial stage of research to understand cancer biology. This review provides insights into targeted therapies and immunotherapies that have emerged using in vitro models and microbiome analysis. It focuses on therapeutic development using cell lines and the limitations of tumor heterogeneity and microenvironment. We explore the evolving landscape of breast cancer cell lines from two‐dimensional (2‐D) cultures to patient‐derived xenograft (PDX) models advancing both fundamental and translational research. Patient‐derived xenografts, cell line‐derived xenografts (CDX), three‐dimensional (3‐D) cultures, organoids, and circulating tumor cells (CTC) models provide promising alternatives that capture the intricacies of the tumor microenvironment. This review bridges the gap between traditional cell lines and newer developments exploring the therapeutic and diagnostic advancements and needs for cell lines to expedite the progress in breast cancer research and treatment.
Funder
Indian Council of Medical Research
Defence Science and Technology Group
Douglas Bomford Trust
Reference89 articles.
1. WHO.Breast Cancer Details.2023. Accessed July 2023.https://www.who.int/news-room/fact-sheets/detail/breast-cancer
2. Globocan.TGCO.Estimated Age‐Standardized Incidence Rates (World) in 2020 India Both Sexes All Ages(excl. NMSC). 2020. Accessed July 2023.https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf
3. MASTL: A novel therapeutic target for Cancer Malignancy
4. Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation
5. Targeted inhibition of MASTL kinase activity induces apoptosis in breast cancer
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献